Infosys announced a new partnership with paperless validation company ValGenesis, that will bring even stronger compliance and quality management for its customers in the healthcare and life sciences sectors. Under the partnership, Infosys will integrate ValGenesis' Validation Lifecycle Management System (VLMS) within its suite of services for the pharmaceutical and biotech industry, which will be delivered in a rapidly deployable, highly secure cloud environment. Validation systems are still almost entirely manual, paper-based process, resulting in significant inefficiencies, higher costs and more significant opportunity for errors to creep in. They can also result in delays to life-saving medicines and procedures to patients. ValGenesis' VLMS includes a regulatory framework allowing validation requirements to be specified in advance. Risk Management, a key component of VLMS, is integrated and flexible, giving companies the ability to leverage standard risk tools to best suit their needs. Reusability is inherent and available at test and requirement levels, significantly improving efficiency via pre-approvals. Consistency is also driven by standardization which improves a company's compliance posture.